BioElectronics Announces New Distribution Agreements for China, the Middle East and Other Global Opportunities
BioElectronics Corporation. (OTC-PINK: BIEL), the maker of inexpensive, disposable drug-free topical pain and healing devices, today announced an agreement with Shanghai Lixiu Medical Devices Co., Ltd. - a subsidiary of Shanghai SuoKang Medical Implants Co., Ltd. -- to sell BIEL's RecoveryRxT, chronic wound and surgical devices, throughout the People's Republic of China to licensed medical providers.
Lixiu is a premier company engaged in the sales of medical devices.
Lixiu successfully registered and marketed SuoKang's medical implants and surgical patch for the treatment of facial tissues defects and deformities, to more than 1,400 medical institutions throughout China.
In collaboration with BIEL, Lixiu will also provide extensive clinical research for BIEL in China, where the Company has extensive patent coverage.
BIEL also recently announced that it has retained the services of Orian Healthcare (www.orianhealthcare.com) to be its sales agent in the Middle East. Based in the United Kingdom, Orian Healthcare has displayed a proven ability to build brand and reach consumers in new and developing markets. Also, BIEL has signed a distribution agreement with Juno Pharmaceuticals, India (www.junopharm.com), which was recently formed by experienced Indian and Canadian private equity fund managers to focus on global opportunities for pharmaceuticals and medical devices.
"We are also presenting our products to retailers throughout both Western and Eastern Europe," said Andrew Whelan, BioElectronics Corporation President. "Our purpose is to sell our excellent products worldwide using the very best distributors and retailers," Mr. Whelan said.
About BioElectronics Corporation BioElectronics is an award winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch@ Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the AllayT Menstrual Cycle Pain Therapy, and RecoveryRxT for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and swelling. For more information, please see www.bielcorp.com.
Contact: E & E Communications Paul Knopick (949) 707-5365 email@example.com SOURCE BioElectronics Corporation -0- 03/05/2012 /Web Site: http://www.orianhealthcare.com http://www.bielcorp.com http://www.junopharm.com (OTC-PINK:BIEL) / CO: BioElectronics Corporation; Shanghai Lixiu Medical Devices Co., Ltd.; Orian Healthcare ST: Maryland China Middle East IN: HEA MTC MEQ SU: PDT LIC CXP PRN -- LA64126 -- 0000 03/05/2012 11:20:00 EDT http://www.prnewswire.c